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1  Introduction
The development of new potential diagnostic strategies 
for the immunodetection of pathogens is closely linked 
to the discovery of small polypeptides with immunogenic 
or immunoreactive activity. For this purpose, it would 
be better if these peptides are specific and located in the 
bacterial cell surface. Specificity is negatively related to 
the conservation of the sequence of that epitope among 
bacterial species that could be in contact with the same 
host: If the immunoreactive epitope has a very well 
conserved sequence, the probability that the host is 
immunized against that epitope is high and could bring 
to a high rate of cross-reaction. Moreover, the location in 
the bacterial cell wall also represents a critical element. In 
fact, the immunization against a bacterial protein is easier 
if the protein is located in the surface because it has higher 
probability to be in contact with host immune system [1].
The increasingly large availability of fully sequenced 
pathogens genomes has increased the possibility to 
study in silico the presence of epitopes useful for the 
diagnosis. Therefore synthetic peptides could be created 
for the preparation of antigenic cocktails useful as 
high-throughput platform for immunological testing. 
However, it is not feasible to perform the complete in silico 
bioinformatic analysis totally avoiding a bench approach. 
The bench approach is necessary in order to obtain 
targeted preliminary data and to proceed with the in silico 
analysis (Fig.1).
Vaccination also represents a key point in public health 
advances with important goals such as worldwide 
eradication of diseases as smallpox and poliomyelitis. 
Vaccines are usually made with the pathological agent 
attenuated or killed and the immunization is made 
by injection. This practice has, as positive effect, the 
immunization of the patient but also presents some 
negative effects. For example, these negative effects 
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could be due to the stimulation of a high and unwanted 
host immune response against self-structures linked to 
molecular mimicry mechanisms. Mainly for these reasons, 
the vaccination through specific synthetic peptides could 
represent the solution to overcoming these problems. One 
of the most significant contributions of this approach 
resulted in the production of antigens used for vaccination 
against cancer [2].
There are two different types of epitopes that could be 
recognized by immune cells or antibodies, the continuous 
and the discontinuous ones. The continuous epitopes 
consist in short linear fragments of an antigen; the 
discontinuous ones are formed by aminoacid residues 
brought together by the secondary structure of a protein 
ad are dependent from the protein folding. According to 
a peptidomic point of view, among these two classes of 
antigens, the most important are the continuous ones 
because of the simpler procedure of synthesis that is 
independent from protein folding [3].
As stated before, the availability of a high number of 
bacterial sequences enhances the possibility of  in silico 
analysis. However, a bench approach is necessary in order 
to obtain experimental data useful to support bioinformatics 
results. The methods able to provide important information 
are mainly related to proteomics approaches. One of the most 
powerful techniques is represented by 2D electrophoresis 
followed by immunoblotting (2D immunoblotting) and 
mass spectrometry analysis for the identification of 
immunoreactive protein spots [4] (fig. 1). This approach 
provides reliable data on the presence of immunogenic 
proteins and on their sequence. Moreover if the experimental 
design also includes a comparison between  infected and 
control samples, it is possible to evaluate if these proteins 
are specifically recognized by infected host [5]. Another 
promising approach is based on the enzymatic shaving of 
bacterial surfaces [6]. This procedure consists in two steps: 
treatment of the intact bacterial cells with trypsin and mass 
spectrometry analysis of shaved peptides. This provides, 
with good confidence, the knowledge about proteins that are 
partly exposed out of the bacterial cell wall.
The biggest challenge in veterinary medicine is 
represented by the constant request of detection methods 
for an early diagnosis of pathologies in their subclinical 
stage. Several pathologies are indeed diagnosed once 
Figure 1. Peptidomics workflow for detection of antigenic peptides.
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the advanced clinical status is coming leading to an 
increase of expenses in the management [7]. In this 
field, one of the worst pathologies is represented by 
bovine paratuberculosis. A huge work has been done for 
the detection of novel epitopes useful for its diagnoses. 
Nevertheless, to date there is no well applicable 
documented progress and the subclinical form is still very 
difficult to diagnose. 
The aim of this review is to summarise all the advances 
that have been made to date in the field of the diagnosis 
and vaccine through the discovery of immunogenic 
peptides. In recent years many protein and peptides have 
been widely described, but it is still missing a complete 
list of all obtained data useful to provide exhaustive and 
comprehensive information for future studies on putative 
diagnoses and vaccines.
In this context it will be underlined how the 
complementary use of both bench and in silico approaches 
could lead to reliable results useful to the synthesis 
of immunoreactive peptides to be used as vaccines or 
diagnostic tools.
2  Bovine paratuberculosis (Johne’s 
disease/JD) and its impact on 
veterinary industry and on human 
health
The widespread use of antibiotics and their relation with 
the increase of antibiotic resistance is a great concern 
worldwide. In this field, a correct and rapid diagnosis plays 
a pivotal role.  The later the diagnoses is performed, the 
higher is the possibility of infection spread and the amount 
of antibiotics needed in order to counteract the infection 
[8]. This topic is relevant in the light of the evidences of 
the increasing problems of drug and multidrug resistance 
[9]. For these reasons, bovine paratuberculosis has been 
chosen as the keynote study.
Bovine paratuberculosis is caused by MAP and 
is characterized by a systemic infection and chronic 
inflammation of the intestine in animals [10]. It is spread 
worldwide and is the cause of huge economic loss for 
animal production [11]. The economic loss is due to 
lower conversion index of food, to higher veterinary 
costs, lower milk and meat production, lower value at 
slaughterhouse and of the whole breeding. Considering 
that cattle business represents the most important part of 
animal products for human consumption and that bovine 
paratuberculosis is spread worldwide, the financial loss is 
currently still underestimated [12].
Moreover, there is considerable evidence that 
documents how this disease could also be a zoonosis 
[13]. Crohn’s disease (CD) is a chronic inflammation of the 
intestine in humans very similar to Johne’s disease which 
was spread in Europe and North America. There are many 
pieces of experimental evidence that document how MAP 
could be the etiologic agent. One of the most interesting 
type of studies in this field is related to the evaluation 
of CD incidence in individuals with environmental or 
occupational exposure [10]. This study has been performed 
in US and demonstrated how this cluster of individuals 
was associated with a significantly reduced death rate 
due to inflammatory bowel diseases (IBD) [14].  This 
evidence demonstrates both that a link between these two 
pathologies could exist, both that exposure to antigens, 
even in humans, could generate an immunization process 
against this pathogen. Another really interesting result 
comes from the study of population movement and this 
pathogen [10]. Particularly interesting is the study that 
describes what happened in Iceland: after introduction 
of MAP via Karakul sheep imported from Germany, the 
increasing incidence of JD rate in sheep, cattle, and, 
afterwards, incidence of CD in humans increased up to 18 
folds [15, 16].
There are many pieces of experimental evidences that 
document the presence of MAP in blood and mucosal 
biopsies [17-20].
Several cases document how MAP infection could 
be involved in the onset of autoimmune diseases in 
humans. Many MAP proteins, such as hsp65, have been 
previously identified as immunodominant antigens that 
stimulate humoral and T-cell mediated response during 
mycobacterial infection [21]. hsp65 has, in its sequence, 
characteristic epitopes that resemble humans structures 
and, the immunization against this protein could generate 
the production of antibodies against self-structures. This 
similarity is the base of the proposed etiopathological 
mechanism (molecular mimicry) that stimulates the 
production of autoantibodies associated with autoimmune 
diseases as type 1 diabetes, Hashimoto’s thyroiditis, and 
multiple sclerosis [22].
These evidences contribute to underline the hazards 
that this pathogen represents for public health [23].
3  Bovine paratuberculosis 
diagnosis and vaccines
The biggest actual challenges of veterinary industry 
against Johne’s disease are still the diagnosis and 
vaccination. The disease spread could be avoidable 
Brought to you by | Università degli Studi di Milano
Authenticated
Download Date | 11/30/15 5:47 PM
4   C. Piras et al.
only through the diagnosis of the subclinical infection. 
What is actually happening is that, considering a herd, 
for every cow that has been successfully diagnosed, 
there is an average number of roughly 15-20 cows that 
are infected but cannot be diagnosed [24]. Among 
diagnostic methodologies there are the serological 
tests, such as ELISA, that are mostly used to confirm 
the presence of this pathology in cattle with evident 
clinical signs. Because of its relatively short turnaround 
time and low cost it is the most frequently used. 
However commercial ELISA tests are unable to detect 
early infections and the use of this technique for the JD 
diagnosis is still questionable. ELISA is able to detect 
about 40% of diseased cattle that could be detected 
by faecal culture methods [25]. Considering that faecal 
culture has a sensitivity of about 50%, the final rate of 
sensitivity of ELISA test is very low.
Methods for the investigation of cell-mediated 
immunity, as hypersensitivity methods (skin test), could 
also be used for diagnosis. However, these methods fail 
to be useful for a reliable diagnosis because of the lack 
of specificity and high rates of false positive and false 
negatives [26].
As a reliable test is needed for subclinical 
paratuberculosis diagnosis, effective vaccine is also 
required. To date, the paratuberculosis vaccines are made 
with live attenuated or killed bacteria. The vaccination 
is necessary for the prevention of clinical cases but it 
interferes with the interpretation of skin tests for bovine 
tuberculosis. This represents the main reason why 
vaccination is prohibited in many countries.
4   Literature on diagnoses and 
putative peptides to be used
As stated before, to date, for bovine paratuberculosis 
diagnosis, several serological tests have been developed. 
However, lack of sensitivity and specificity [27] still 
represents a problem and the selection of proteins 
belonging form MAP surface could represent a possible 
solution [28].
Many studies have been conducted in order to enhance 
knowledge and methods for bovine paratuberculosis 
diagnosis.  The recent advantages in the field of proteomics 
and peptidomics  have contributed to an increase in the 
number of alternative approaches for paratuberculosis 
diagnosis. The high resolution of 2D gel-electrophoresis 
coupled to the powerful tool of mass spectrometry lead 
to the identification of several hundred interesting MAP 
proteins.
Mikkelsen and colleagues [29] provided a table 
containing all information separated according to the 
type of antigen. Antigens list was divided in two groups, 
antigens responsible for cell-mediated immunity and 
antigens responsible for humoral immunity that is the 
most promising  application in  the diagnostic field.
In this review table 1 summarises all the details about 
the antigens responsible for the humoral immunity, 
modified from Mikkelsen and colleagues [29], and updated 
with all the currently available data.  In the previous study, 
all the immunoreactive epitopes both for humoral and cell-
mediated immunological response have been listed. In 
this context they have been revised all the epitopes closely 
linked to humoral response whose protein sequence was 
well annotated in order to provide the basis for further in 
silico analysis of the immunoreactive epitopes. The overall 
representation of these data has been filtered considering 
protein information available. According to experimental 
evidences and functions, these proteins play a key role in 
the pathogenicity of MAP and in its ability to stimulate the 
host humoral response. In table 1 it has been described, 
where possible, the main cellular function in which every 
protein could be involved and the most relevant GO terms. 
The cellular compartment has been also provided where 
possible according to GO annotations. For each protein 
it has been provided the Uniprot accession number in 
order to facilitate the availability of the protein and gene 
sequence that could be useful for further studies.
These revised information about all describes epitopes 
could provide an important starting point for the in silico 
analysis of immunoreactive specific epitopes. According 
to our knowledge, the proteins and relative peptides in the 
following table are able to stimulate antibodies production 
in animals.
Table 1. Table integrating all protein epitopes up to 
date and according to Mikkelsen  [29]. All references are 
on the right column, only first author has been reported, 
whole reference is present in the references section [4, 
30-57].
5  Laboratory methods and bioin-
formatics tools for immunoreactive 
epitope prediction
Antibodies reflect  health: they are a feature in diseases 
such as autoimmune diseases, cancer or infections. One 
important feature of antibodies is their relative easy 
availability. Because they are carried in the bloodstream, 
their screening is simply a matter of blood sample 
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analysis and require as input a fasta sequence or uniprot 
accession number.
Another problem to overcome before accurately 
choosing the peptide to synthesize is related to the 
conserved sequences of epitopes.  It is always better not 
to choose conserved sequences in order to avoid cross-
reactivity problems. In order to overcome these problems 
it is really important to use the tool made by Marchler-
Bauer and colleagues (http://www.ncbi.nlm.nih.gov/
Structure/cdd/wrpsb.cgi) that is useful for the search of 
conserved domains [78].
6  Future perspectives
Increasing resistance to antibiotics has led to a necessary 
improvement of side strategies to overcome infections such 
as early diagnosis or vaccination. Genomics, proteomics, 
immunoproteomics and peptidomics are able to provide 
necessary information in order to improve research 
and outcome on this field. For what it concern bovine 
paratuberculosis, several progresses have been made both 
from bench and in silico approach. In this review it has been 
provided the latest summary of experimental evidences 
of the proteins involved in the stimulation of humoral 
immunity against MAP (Table 1). All listed information, 
together with bioinformatics approaches described in 
paragraph 6, are able to provide the bases for future 
studies starting from the synthesis of immunoreactive 
antigens (peptides) to be screened as putative vaccines or 
as diagnostic tools. This approach could be applied in the 
research field of many infectious diseases.
Despite the several advances in the study and in the 
prediction of linear epitopes for diagnosis and vaccines, 
a lot of work still has to be done, in particular about the 
topic of post-translational modifications. Indeed, the 
antibody-antigen interaction could be due not only to a 
linear motif, but to the glycans attached to amminoacid 
residues.
In the light of future perspective, a promised 
application in the discovery of vaccine candidates, is 
represented by the study of post translational modification 
as reported by Facciuolo and Mutharia. In this work, they 
focus attention on glycosylation as targeted candidate for 
both diagnosis and vaccine [79].
Glycans often represent the first host-pathogen 
contact and in particular O-antigen heterogeneity is often 
used for diagnostic purposes in other bacterial species 
and serotypes [80].
About this topic it would be relevant to test the 
described antigens both before and after protein 
withdrawal. However, it is not always easy to find the 
right epitopes to get reliable antibody response that well 
reflects the disease status.
In this field a great progress has been made through 
immunoproteomics. One of the most powerful approaches 
is characterized by 2D electrophoresis approach followed 
by immunoblotting and MS (serological proteome 
analysis, SERPA). This approach allows the detection and 
the identification of specific immunoreactive epitopes and 
proteins and represents one of the most used [58].
Among gel-free approaches, there are many methods 
to discover and identify immunogenic proteins. Protein 
array is probably the most common approach and is 
characterized by the fractionation and immobilization of 
antigens according to their features such as hydrophobicity 
or pI [59-61]. The advantage of this technique is that, in 
most cases, the protein structure remains intact and 
antibodies can even bind nonlinear epitopes. On the 
contrary, the immunocapture-MS approach requires the 
immobilization of antibodies that will bind antigens that 
afterwards can be detected through mass spectrometry 
technique [58, 62-64].
Once immunoreactive protein has been detected, it 
is important to go on with epitope mapping through the 
synthesis of libraries of immunoreactive peptides. To 
avoid the synthesis of peptides that have no possibility 
to be immunoreactive, several bioinformatics tools have 
been developed.
As previously stated, two types of epitopes exist, the 
continuous and the discontinuous. The continuous ones 
are constituted by peptides in their linear sequence and 
are easier to prepare because the epitope formation is 
not dependent on the protein folding. However, there are 
many regions of a protein that have no chances to become 
a B-cell epitope (i.e. the trans-membrane regions). For 
this reason, in order to avoid the random synthesis and 
screening of peptides to be tested, some key bioinformatics 
tools have been proposed to suggest the best sequences 
for the synthesis [65].
Several studies have already successfully detected 
immunoreactive B-cell epitopes using computational 
approaches and some of them are described here [66-68]. 
CBTOPE (http://www.imtech.res.in/raghava/cbtope/) is 
an algorithm from Ansari and colleagues for the prediction 
of B-cell immunoreactive epitopes starting from a protein 
FASTA sequence [1]. There are many algorithms that can 
be used for this purpose as Lbtope (http://crdd.osdd.net/
raghava/lbtope/) [69], BEST [70] and many others [71-75].
EpiC (http://bioware.ucd.ie/epic/) [76] and IEDB 
Analysis Resource (http://tools.immuneepitope.org/
bcell/) [77] also represent complete tools for epitope 
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deglycosylation in order to evaluate the putative role of 
glycans in a specific protein immunoreaction. However, 
there are several novel tools that are able to predict 
where a protein glycosylation may occur and could be 
successfully used in the epitopes prediction process. 
One of the future perspective is represented by the 
development of novel methods for the characterization 
and the study of bacterial glycosylation process and glycan 
structures. Some databases able to help for this task are 
already present. However, even if the structure has been 
characterized, their putative synthesis remains a difficult 
task to be feasible in order to cast diagnostic tools. For this 
reasons, to date, it remains a better choice to focus efforts 
on the prediction and on the synthesis of peptides which 
are easier to sequence and synthesise.
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